What is the current valuation of the portable diagnostic-devices market in India as of 2024?

The market valuation was $4311.66 Million in 2024. Read More

What is the projected market size for portable diagnostic devices in India by 2035?

The projected valuation for 2035 is $11173.0 Million. Read More

What is the expected CAGR for the portable diagnostic-devices market in India during the forecast period 2025 - 2035?

The expected CAGR during this period is 9.04%. Read More

Which segments contributed to the portable diagnostic-devices market valuation in 2024?

In 2024, Diagnostic Imaging and Monitoring Devices were key segments, valued at $1500.0 Million and $2811.66 Million respectively. Read More

What are the primary applications of portable diagnostic devices in India?

Key applications include Gynecology, Cardiology, Gastrointestinal, and others, with valuations ranging from $431.17 Million to $1640.0 Million. Read More

Who are the leading players in the portable diagnostic-devices market in India?

Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and others. Read More

What is the market size for homecare settings in the portable diagnostic-devices market?

The market size for homecare settings was $1000.0 Million in 2024. Read More

How do hospitals and clinics contribute to the portable diagnostic-devices market?

Hospitals and clinics contributed $1500.0 Million to the market valuation in 2024. Read More

What is the valuation range for the monitoring devices segment in the portable diagnostic-devices market?

The monitoring devices segment is projected to range from $2811.66 Million to $7173.0 Million. Read More

What is the significance of the 'Others' category in the application segment?

The 'Others' category in the application segment holds a valuation of $1.0 Million, indicating niche applications. Read More

India Portable Diagnostic Devices Market

ID: MRFR/MED/47775-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

India Portable Diagnostic Devices Market Research Report By Type (Diagnostic Imaging, CT, X-Ray, Ultrasound, Endoscopes, Monitoring Devices, Cardiac Monitoring, Holter Monitors, Resting ECG System, Stress ECG Monitors, Event Monitoring Systems, ECG Management Systems, Neuromonitoring, EEG Machines, EMG Machines, ICP Monitors, MEG Machines, Cerebral Oximeters, Respiratory Monitoring, Capnographs, Spirometers, Peak Flow Meters, Ophthalmic Monitoring, Fundus Cameras, Tonometry Devices, Others, Hemodynamic Monitoring Systems, Vital Sign Monitors, Smart Wearable Medical Device, Others), By Application (Gynecology, Cardiology, Gastrointestinal, Urology, Neurology, Respiratory, Orthopedics, Ophthalmology, Others) and By End User (Hospitals and Clinics, Diagnostic Centers, Homecare Settings, Others) -Forecast to 2035

English

India Portable Diagnostic Devices Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Type (USD Million)
  1. 4.1.1 Diagnostic Imaging
  2. 4.1.2 Monitoring Devices
2. 4.2 Pharmaceutical, BY Application (USD Million)
  1. 4.2.1 Gynecology
  2. 4.2.2 Cardiology
  3. 4.2.3 Gastrointestinal
  4. 4.2.4 Urology
  5. 4.2.5 Neurology
  6. 4.2.6 Respiratory
  7. 4.2.7 Orthopedics
  8. 4.2.8 Ophthalmology
  9. 4.2.9 Others
3. 4.3 Pharmaceutical, BY End User (USD Million)
  1. 4.3.1 Hospitals & Clinics
  2. 4.3.2 Diagnostic Centers
  3. 4.3.3 Homecare Settings
  4. 4.3.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche Diagnostics (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Siemens Healthineers (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Philips Healthcare (NL)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Becton Dickinson and Company (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Thermo Fisher Scientific (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Medtronic (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Johnson & Johnson (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 INDIA MARKET ANALYSIS BY TYPE
3. 6.3 INDIA MARKET ANALYSIS BY APPLICATION
4. 6.4 INDIA MARKET ANALYSIS BY END USER
5. 6.5 KEY BUYING CRITERIA OF PHARMACEUTICAL
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF PHARMACEUTICAL
8. 6.8 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
9. 6.9 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
11. 6.11 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
12. 6.12 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Million)
13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
14. 6.14 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 PHARMACEUTICAL, BY END USER, 2024 (% SHARE)
16. 6.16 PHARMACEUTICAL, BY END USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

India Pharmaceutical Market Segmentation

Pharmaceutical By Type (USD Million, 2025-2035)

Diagnostic Imaging
Monitoring Devices

Pharmaceutical By Application (USD Million, 2025-2035)

Gynecology
Cardiology
Gastrointestinal
Urology
Neurology
Respiratory
Orthopedics
Ophthalmology
Others

Pharmaceutical By End User (USD Million, 2025-2035)

Hospitals & Clinics
Diagnostic Centers
Homecare Settings
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”